EMEA-002164-PIP01-17-M02

Key facts

Active substance
  • (RS)-Bacoflen
  • Naltrexone HCl
  • D-Sorbitol (PXT3003)
Therapeutic area
Neurology
Decision number
P/0030/2020
PIP number
EMEA-002164-PIP01-17-M02
Pharmaceutical form(s)
Oral solution
Condition(s) / indication(s)
Treatment of Charcot-Marie-Tooth disease Type 1A
Route(s) of administration
Oral use
Contact for public enquiries
Pharnext SA

Tel. +33 1 41 09 22 59
E-mail: sdorn@pharnext.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating